For laboratory research use only. Not for human or veterinary use, and not evaluated by the FDA. Documentation shown is supplier-provided.
01 · The vial
Labelled with compound, concentration, lot, and research-use-only status.
GLP-1 Research
GLP-3 RT
5mg, with its supplier Certificate of Analysis published before you order. Without sourcing roulette, unlabelled vials, or crypto-only checkout.
- Supplier COA on every batch, published on this page, readable before you pay.
- Identity you can verify, CAS 2381089-83-2, molecular formula and weight listed, cross-checkable on PubChem.
- No testing claims we cannot back, Provyd runs no in-house testing and says so, documentation is supplier-provided.
- Card checkout, US dispatch, tracked, shipment protection included on every order.
For in-vitro laboratory research use only. Not for human or veterinary use.
Select size
Bundle & save
Subscribe & save is available on eligible catalog items at checkout.
Placed today? Ships within one business day.
Free shipment protection on every order.
For laboratory research use only. Not for human or animal use.
Questions on documentation? Open the COA Center
48
Studies cited
every DOI verified
12
Compounds documented
with primary literature
99%+
Supplier-stated purity
per batch COA
100%
Orders tracked
shipment protection included
Before you order
Is documentation included?
Yes, a supplier COA is published for every batch and can be viewed before you order.
Do you test it yourselves?
No. Provyd runs no in-house or independent testing, and all documentation is supplier-provided.
Is this for human use?
No. Every compound is sold strictly for in-vitro laboratory research.
How fast does it ship?
Orders dispatch from the US with tracking, typically within one business day of ordering.
Can I pay by card?
Yes, standard card checkout with a verified researcher account, and no crypto is required.
What if it arrives damaged?
Shipment protection covers replacement, with the details set out in our guarantee.
Certificate of Analysis
Certificate of Analysis
Supplier-provided documentation
The details below reflect what a supplier COA reports. Provyd does not run its own laboratory testing and does not claim independent or third-party verification. Read every value as a supplier statement, and confirm it against the document supplied with your order.
- Purity (HPLC)
- As stated on supplier COA
- Identity (MS)
- Mass-confirmed on supplier COA
- Net peptide content
- As stated on supplier COA
- Heavy metals
- Per supplier documentation
- Sterility
- Per supplier documentation
- Endotoxin
- Per supplier documentation
Placeholder structure shown for demonstration. Specific purity percentages and lot numbers appear only on the supplier document itself, not as Provyd-tested figures.
View COA CenterInspect it yourself
Six things worth checking on any research-chemical order, and what you get here versus what the category typically does.
Provyd
Aluminium crimp seal intact and unbroken, stopper embossed. A seal that arrives compromised is grounds for replacement.
Typical research-chemical vendor
Loose or re-crimped caps are common, with no stated policy if the seal arrives broken.
Describes common practices in the research-chemical category, not any specific company. Provyd performs no independent or third-party testing, and all documentation referenced is supplied by the manufacturer.
Frequently researched together
Sibling concentrations and adjacent references researchers commonly study alongside this one.
Compound information
GLP-3 RT 5mg is a research-use-only reference for multi-receptor incretin catalog work. The 5mg format supports controlled comparison and supplier-provided documentation review.
Researchers may compare GLP-3 RT with GLP-1, GIP, and glucagon-pathway reference materials in structured research models. Evaluation should remain analytical, documentation-based, and research-only.
Researchers commonly compare against
- Sibling concentrations of the same compound
- Adjacent GLP-1 Research references
- Vehicle and control materials
- Supplier-provided documentation and lot records
Molecular profile
- Type
- GLP-1 Research
- Compound
- GLP-3 RT
- Concentration
- 5mg
- CAS number
- 2381089-83-2
- Molecular formula
- Not listed
- Molecular weight
- ≈ 4731 g/mol
- Sequence
- Not listed
Reference identifiers are shown for research reference only. Verify them against the supplier-provided COA.
Storage & stability
Store according to the supplier-provided documentation. Keep sealed, protected from light, and logged against lot and concentration in your inventory records.
Published literature
Peer-reviewed research on this compound, cited so you can read the primary sources yourself. Every DOI and PMID below was checked to resolve.
State of the evidence
Human data available through phase 3; multiple randomized placebo-controlled trials in obesity, type 2 diabetes and steatotic liver disease. Not approved by FDA or EMA as of July 2026.
- Human clinical trialNew England Journal of Medicine · 2023
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
Jastreboff AM, et al.
In 338 adults with obesity, retatrutide reported a least-squares mean body weight change of -24.2% at 48 weeks in the 12 mg group versus -2.1% with placebo.
- Human clinical trialThe Lancet · 2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Rosenstock J, et al.
In 281 adults with type 2 diabetes, retatrutide reported least-squares mean HbA1c reductions from baseline at 24 weeks ranging from -0.43% at 0.5 mg to approximately -2.0% at higher doses, compared with placebo and dulaglutide 1.5 mg comparators.
- Human clinical trialNature Medicine · 2024
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Sanyal AJ, et al.
In 98 participants with metabolic dysfunction-associated steatotic liver disease, retatrutide reported a mean relative change in liver fat at 24 weeks of -82.4% at 12 mg versus +0.3% with placebo, with normal liver fat (<5%) reached by 86% of the 12 mg group.
- Human clinical trialThe Lancet · 2026
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
Bajaj HS, et al.
In 537 adults with type 2 diabetes, retatrutide 12 mg reported a mean HbA1c change of -1.94% and a mean body weight change of -15.3% versus -0.81% and -2.6% respectively with placebo.
These references are provided as scientific context on the compound for qualified researchers. They describe published research findings, not results from Provyd products, and are not a representation that any product will produce any outcome. Provyd sells materials for in-vitro laboratory research use only. Nothing here is medical advice or an endorsement of human or veterinary use.
Catalog Experience Reviews
Reviews cover ordering, documentation, labeling, shipping, and support, not product outcomes.
Demo seed reviews, not verified customer outcomes
Packaging and records tidy
Packaging was tidy and the included order records matched the catalog listing exactly.
Simple, well-organized page
Well-organized product page. Research category and supplier-provided documentation status were easy to read.
Helpful with a records question
Support answered a documentation-records question quickly and pointed me to the COA Center.
Documentation easy to locate
Supplier-provided documentation was easy to find and the concentration was clearly labeled on the catalog page.
Our guarantee
Ordered with confidence, or we make it right
Four commitments that cover how your order arrives and what documentation comes with it. Materials are supplied for laboratory research use only.
Shipment protection on every order
If your order is damaged, lost, or stolen in transit, we replace it at no cost to you.
Documentation guarantee
If the supplier COA for your batch turns out to be unavailable, you get a full refund.
Labelling accuracy
If the vial does not match the compound and concentration shown on the listing, we replace it or refund it.
Claims window and evidence
Send photo evidence within 10 days of delivery. Opened or reconstituted vials are not eligible.
Provyd runs no in-house or independent testing. All documentation referenced here is supplier-provided.
Important research notice
All products sold by Provyd are intended strictly for in-vitro laboratory research use only. They are not for human or animal consumption and are not drugs, foods, cosmetics, or dietary supplements. They are not intended to diagnose, treat, cure, or prevent any disease and have not been evaluated by the U.S. Food and Drug Administration. Documentation shown is supplier-provided unless otherwise stated.
This compound carries higher regulatory sensitivity. Provyd lists it for laboratory research use only and makes no human-use, outcome, or efficacy claims of any kind.